Serotonin syndrome
Overview
Serotonin syndrome (SS) = excess serotonergic activity, usually from two serotonergic drugs acting via different mechanisms. Key receptor: 5-HT2A mediates the neuromuscular and autonomic features.
Presentation
Symptoms begin within 6 hours of the precipitating event. Classic triad:
•Autonomic hyperactivity - tachycardia, hypertension, hyperthermia, diaphoresis, mydriasis, hyperactive bowel sounds
•Neuromuscular abnormalities - clonus (hallmark sign, especially inducible ankle clonus), hyperreflexia, tremor, muscle rigidity, ocular clonus
•Altered mental status - agitation, anxiety, confusion, delirium, coma
Investigations
•CK - elevated in rhabdomyolysis (key complication of muscle rigidity/hyperthermia)
•U&Es/creatinine - screen for AKI
•Clotting/LFTs - DIC and hepatic injury in severe hyperthermia
•ECG - tachycardia expected; exclude QTc prolongation
•Serial temperature monitoring - hyperthermia >41°C = severe disease
Management
Prognosis
•Most mild-to-moderate cases resolve within 24-72 hours of stopping the offending drug
•Sustained hyperthermia >41°C carries significant morbidity/mortality without ICU escalation
Causative drugs
•SSRIs (e.g. sertraline, citalopram, fluoxetine)
•SNRIs (e.g. venlafaxine, duloxetine) - inhibit serotonin AND noradrenaline reuptake
•MAOIs (e.g. phenelzine) - prevent serotonin breakdown
•Tramadol - weak opioid but also inhibits serotonin/noradrenaline reuptake; high-risk when added to an SSRI
•Triptans (e.g. sumatriptan) - risk when combined with SSRIs
•St John's Wort
Diagnosis - Hunter Criteria
SS is a clinical diagnosis - no confirmatory blood test. Hunter Serotonin Toxicity Criteria: serotonergic drug exposure PLUS any ONE of:
•Spontaneous clonus
•Inducible clonus + agitation or diaphoresis
•Ocular clonus + agitation or diaphoresis
•Tremor + hyperreflexia
•Hypertonia + temperature >38°C + ocular or inducible clonus